CAPTRUST Financial Advisors

Institutional investor · Portfolio as of Q2 2026

Top Holdings3,274 positions

Checking export access…
Activity:
IVV
IVV
ETF

ISHARES S&P 500

4.7M$3.5B5.3%$568.67+34.19%
9 qtrssince 2024-Q2
Increased
67
AAPL

Apple Inc.

8.1M$2.4B3.6%$167.84+107.65%
31 qtrssince 2018-Q4
Increased
61
VEA
VEA
ETF

VANGUARD FTSE INTL

30.6M$2.2B3.3%$48.40+43.31%
31 qtrssince 2018-Q4
Decreased
0
NVDA

NVIDIA Corporation

8.8M$1.8B2.7%$109.89+53.69%
31 qtrssince 2018-Q4
Increased
60
SHY
SHY
ETF

ISHARES 1-3 YR TREAS

21.1M$1.7B2.6%$77.66+4.71%
31 qtrssince 2018-Q4
Increased
60
VTV
VTV
ETF

VANGUARD VALUE - VTV

6.8M$1.5B2.3%$137.66+65.39%
31 qtrssince 2018-Q4
Increased
56
MSFT

Microsoft Corporation

3.6M$1.4B2.1%$313.19+70.23%
31 qtrssince 2018-Q4
Increased
59
GOOGL

Alphabet Inc.

3.5M$1.3B1.9%$176.11+63.18%
31 qtrssince 2018-Q4
Increased
54
IXUS
IXUS
ETF

ISHARES TR

10.7M$1B1.6%$77.19+19.92%
25 qtrssince 2020-Q2
Decreased
0
AMZN

Amazon.com, Inc.

3.9M$929.6M1.4%$170.65+58.73%
31 qtrssince 2018-Q4
Increased
53
FNDX
FNDX
ETF

SCHWAB FUND LARGE CA

28.8M$897.1M1.4%$23.78+37.83%
25 qtrssince 2020-Q2
Increased
53
VB
VB
ETF

VANGUARD SMALL - CAP

2.9M$883.6M1.3%$214.51+36.67%
31 qtrssince 2018-Q4
Increased
52
VOO
VOO
ETF

VANGUARD S&P

1.2M$822.7M1.3%$455.15+51.49%
31 qtrssince 2018-Q4
Increased
51
IEI
IEI
ETF

ISHRS 3-7 TREAS-IEI

6.8M$803.1M1.2%$112.88+1.49%
31 qtrssince 2018-Q4
Increased
55
IEMG
IEMG
ETF

ISHARES EMERG-IEMG

9.5M$787.5M1.2%——
31 qtrssince 2018-Q4
Decreased
0
AVGO

Broadcom Inc.

2.1M$781.8M1.2%$221.11+50.14%
31 qtrssince 2018-Q4
Increased
62
VUG
VUG
ETF

VANGUARD GROWTH

8.5M$733.6M1.1%$52.51+59.64%
31 qtrssince 2018-Q4
Increased
54
AGG
AGG
ETF

ISHARES AGG BONDS

6.7M$663.5M1.0%$91.69+4.57%
9 qtrssince 2024-Q2
Increased
54
SCHX
SCHX
ETF

SCHWAB STRATEGIC TR

20.4M$599.3M0.9%$21.49+37.44%
31 qtrssince 2018-Q4
Increased
45
SPY
SPY
ETF

SPDR S&P 500

783,901$585.4M0.9%$426.07+76.01%
31 qtrssince 2018-Q4
Decreased
0
$65.5B
AUM
3,274
Positions
Q2 2026
Filing
HI rating · 4.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$39,859,927,63313.8520401236%
2025-Q2$44,819,019,58412.4412969252%
2025-Q3$49,038,258,5939.41394757887%
2025-Q4$52,574,530,4477.21125087934%
2026-Q1$57,304,848,9418.99735756797%
2026-Q2$65,477,943,71314.2624837567%
Activity profile
$ moved · Q2'26
New2%Increased67%Decreased28%Exited3%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 5.1 years
<1Q6%1-4Q7%1-2Y5%2Y+82%

CAPTRUST Financial Advisors manages $65.5B across 3274 positions as of Q2 2026. Top holdings: IVV (5.3%), AAPL (3.6%), VEA (3.3%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.

Q2 2026 Summary

Active quarter - 355 new positions, 118 exits, 1652 increased. Top move: IVV (INCREASED, conviction 67). Portfolio: $65.5B across 3274 positions.

Top holdings by portfolio weight

Total AUM$65B
IVV5.32%
AAPL3.59%
VEA3.33%
NVDA2.69%
SHY2.64%
VTV2.26%
MSFT2.06%
GOOGL1.91%
IXUS1.56%
AMZN1.42%
Other1.37%

Portfolio allocation by GICS sector

Sectors11
Unknown50.41%
Technology17.18%
Financial Services7.18%
Healthcare4.95%
Industrials4.83%
Consumer Cyclical4.16%
Communication Services4.14%
Consumer Defensive2.40%
Energy1.52%
Utilities1.22%
Other2.00%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L56
Conviction49
Concentration40
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
ABBVABBVAbbVie Inc.
Q4 2024 → Q2 2026+588,526 shares+$214.7M
7Q
BCIBCIABERDEEN STANDARD
Q4 2024 → Q2 2026+36,265 shares+$861,597
7Q
ADPTADPTAdaptive Biotechnologies Corporation
Q4 2024 → Q2 2026+10,529 shares+$436,994
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used